Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Astellas Pharma Inc (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Sep 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for ALPMF: the economy's impact on ALPMF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

27 Sep 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

"The Economy Matters" Report for ALPMY: the economy's impact on ALPMY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

27 Sep 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ASTELLAS PHARMA INC (ALPMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Value Graph: ASTELLAS PHARMA -- ALPMY

23 Sep 2016 Ford Investor Services, Inc. 1 $12.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

20 Sep 2016 GlobalData 361 $300.00

Astellas Pharma Inc.

Astellas Pharma Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report cover...

05 Sep 2016 MarketLine 49 $50.00

Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

02 Sep 2016 Wright Reports 65 $75.00

Astellas Pharma Inc. (TOKYO- 4503)

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world throu...

04 Aug 2016 Acquisdata 18 $15.00